C71T
CANCELLED SECTION 71
07/17/2026
Back to search
Official data from USPTO
IMMODULON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
08/11/2026
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
09/24/2018
Registration date
12/31/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/17/2026
Last transaction
08/11/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
GB
Examiner
DICKSON, RACHAEL
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "IMMODULON", where "IMM" is in white and surrounded by a shaded teal circle and "ODULON" is in dark blue. All other instances of the color white in the mark represent background and/or transparent areas only and are not claimed as features of the mark.
Holders and representatives
Holders
Immodulon Therapeutics Limited
Representatives
Alexandra MacKay Stites & Harbison, PLLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; immune modulatorspharmaceutical preparations for treatment of immune system related diseasesdisordersdysregulation; vitamins and vitamin preparations
Class 42
Scientific and technological services and research and design relating theretoresearch and development in the pharmaceutical and biotechnology fields; scientific and industrial analysis and research servicesresearch relating to immune system related diseases and disorders; clinical research in the field of medical sciencemedical and scientific research in the nature of conducting clinical trials; research and development services in the fields of drug discoverydrug discovery productspharmaceuticalsmedicinal diagnosticsbiological productsmedical apparatusdevices and instrumentspharmaceutical drug development services; supply of information in the area of laboratory technologyproviding technology information in the medical diagnostic industry; medical laboratory services; provision of scientific information via Internet portalsproviding scientific information in the field of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related diseasedisorderdysregulation; scientific consultancyconsulting services in the field of the research and development of immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related diseasedisorderdysregulation; consultancy and research in the fields of science and technologyresearch in the pharmaceutical and biotechnology fields; laboratory analysis and diagnostic serviceslaboratory services in the nature of analysis and diagnosis of immune dysregulation; technical consultation and research in the fields of biotechnology and drug discovery; product research and development; providing databases in the fields of science and technologyproviding an on-line computer database in the field of medical and scientific research of immune dysregulation
Class 44
Medical and therapeutic servicestreatment of patients with immuno disorders; medicalhygienic and beauty care for human beings; provision of medical information; advisory services relating to medical servicespreparations and apparatusproviding medical informationconsultancy and advisory services; providing information and advice in the field of healthcare; providing databases and information in the field of healthproviding an on-line computer database featuring information regarding health and nutrition
Publications
History of USPTO decisions and trademark events.
28 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/31/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/08/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/16/2020
FIMP
FINAL DISPOSITION PROCESSED
04/16/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/31/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2019
PUBO
PUBLISHED FOR OPPOSITION
10/15/2019
GPNX
NOTIFICATION PROCESSED BY IB
10/12/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/25/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/25/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2019
ALIE
ASSIGNED TO LIE
09/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/09/2019
RFNT
REFUSAL PROCESSED BY IB
04/06/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/21/2019
RFRR
REFUSAL PROCESSED BY MPU
03/21/2019
MAFR
APPLICATION FILING RECEIPT MAILED
03/15/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/13/2019
CNRT
NON-FINAL ACTION WRITTEN
03/12/2019
DOCK
ASSIGNED TO EXAMINER
03/11/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/11/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
03/08/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/28/2019
Continuous trademark protection
Get notified about every new filing that threatens IMMODULON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.